Product Launch (Blog)

Key Players in the Global Cell Culture Media Market: Innovation and Advancements in Biopharmaceutical and Cell-Based Therapy Production

The global cell culture media market is experiencing significant growth, driven by increasing demand for biopharmaceutical production, tissue engineering, and regenerative medicine. Cell culture media plays a crucial role in providing essential nutrients and growth factors for the cultivation of cells in laboratory and industrial settings. The expanding focus on biologics, personalized medicine, and cell-based therapies is propelling market demand, as these applications rely heavily on optimized cell culture conditions. In addition, advancements in media formulations, such as serum-free and chemically defined media, are improving cell growth and productivity, driving innovation in the field. The rising investments in research and development, particularly in the biopharmaceutical and biotechnology sectors, are also fueling market expansion.

Global Cell Culture Media Market size was valued at USD 6.23 billion in 2023 and is projected to reach USD 14.87 billion by 2031, with a CAGR of 11.5% during the forecast period of 2024 to 2031.

To know more, visit https://www.databridgemarketresearch.com/zh/reports/global-cell-culture-media-market

Below are the Top Cell Culture Media Companies with a Significant Market Share:

Rank

Company

Overview

Product Portfolio

Sales Geographical Coverage

Developments

1.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific offers a comprehensive range of cell culture media solutions that support biopharmaceutical production, cell therapy, and research applications. Thermo Fisher is a key player in the global cell culture media market, providing advanced media formulations, reagents, and bioprocessing technologies to optimize cell culture conditions and improve biomanufacturing efficiency.

In May, Thermo Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers.

North America, South America, Middle East and Africa, Asia-Pacific, and Europe

In May 2023, Thermo Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers.

2.

Merck KGaA

Merck is known for offering a wide range of cell culture products and media solutions that support biopharmaceutical production, cellular therapies, and tissue engineering. Their portfolio includes innovative cell culture systems, reagents, and supplements designed to improve cell growth, protein production, and bioprocessing efficiency for researchers and manufacturers.

  • Cellvento CHO cell culture media
  • Cellvento BHK-200 cell culture medium
  • Customized Cell Culture Media
  • Classical Cell Culture Media

North America, South America, Middle East and Africa, Asia-Pacific, and Europe

In September 2024, Merck has achieved industry-first EXCiPACT cGMP certification for Pharmaceutical Auxiliary Materials at its global cell culture media production sites in Germany, the UK, China, and the USA, ensuring high safety and quality standards for essential raw materials in biomanufacturing.

3.

Danaher Corporation (Cytiva)

Danaher Corporation is a global science and technology innovator with a focus on life sciences, healthcare, and environmental solutions. Its subsidiary, Cytiva, specializes in providing bioprocessing technologies and cell culture media to the biotechnology and pharmaceutical industries. Cytiva offers a comprehensive portfolio of culture media, bioreactors, and filtration systems to support cell culture growth in both research and industrial-scale applications.

  • Cell culture and fermentation processes

North America, South America, Middle East, Asia-Pacific, and Europe

In September 2024, Cytiva has opened its first Innovation Hub in Songdo, Incheon, Korea, featuring a manufacturing facility and customer experience lab. Set to enhance biopharmaceutical manufacturing, the hub aims for sustainable practices and collaboration, supporting growth in the APAC life sciences industry.

4.

Sartorius AG

Sartorius offers a wide array of cell culture media and bioprocessing products, enabling high-quality cell growth, protein production, and cell therapy manufacturing. Sartorius' cell culture media are critical for biomanufacturing, especially in monoclonal antibody production and cell-based vaccines, where high-quality media formulations ensure optimal cell viability and productivity in production processes.

  • Cell Culture Media, Buffers, Reagents, Plasmids

North America, South America, Africa, Asia-Pacific, and Europe

In June 2024, Sartorius has inaugurated a new Center of Excellence for bioanalytics in Ann Arbor, Michigan, investing approximately USD 100 million to consolidate existing operations. The 130,000-square-foot facility will focus on manufacturing bioanalytical instruments, reagents, and consumables, while promoting sustainability through LEED gold certification efforts.

5.

Lonza

Lonza offers a wide range of cell culture media products, including serum-free and protein-free media, designed to support cell growth, bioprocessing, and drug development. The company plays a crucial role in the cell culture media market, helping biomanufacturers optimize their processes for therapeutic protein production, gene therapies, and vaccine development.

  • NEW TheraPEAK T-VIVO Cell Culture Medium
  • TheraPEAK T-VIVO Cell Culture Medium

North America, South America, Middle East, Asia-Pacific, and Europe

In July 2023, Lonza introduced the TheraPRO® CHO Media System, a new cell culture platform designed to enhance productivity and protein quality when used with GS-CHO cell lines. This launch aims to support pharmaceutical and biotechnology companies in manufacturing therapeutic proteins, improving product quality while accelerating time-to-market.

Conclusion

The global cell culture media market is set for sustained growth, driven by the increasing applications of cell culture in biopharmaceutical production, tissue engineering, and regenerative medicine. Innovations in media formulations and the growing demand for biologics are expected to continue propelling the market forward. While challenges such as the high cost of specialized media and formulation complexity exist, the overall outlook remains positive, with substantial investments in research and development contributing to continued innovation and growth in the market.


Client Testimonials